Dr Kit Sturgess 'honoured' to have the role.
Cats Protection has appointed Dr Kit Sturgess, specialist in small animal internal medicine, as its new Chair of Trustees.
Dr Sturgess has taken over the role from Dr Angela Swarbrick, Interim Chair since February 2020.
A Cats Protection trustee since 2018, Dr Sturgess is also the editor-in-chief of the open access journal Veterinary Evidence, which publishes studies and information on evidence-based veterinary evidence.
Taking over the role with a wealth of experience in leadership, Dr Sturgess has also been Chair of Trustees for the Wildheart Trust and treasurer for the Royal College of Veterinary Surgeons (RCVS).
Interim chief executive of the charity, Dominic Sullivan, commented on the appointment: “I am looking forward to working with Kit as he takes up his new role.
“His extensive knowledge of small animal medicine combined with his leadership skills and love of cats make him a real asset to Cats Protection as we continue to make a positive difference to the nation’s cats in the years ahead.”
Dr Sturgess graduated from Cambridge University in 1986, and has since gained several further professional qualifications in imaging, cardiology and internal medicine, including a PhD awarded for his research on the effects of feline immunodeficiency virus (FIV) on mucosal immune function.
Awarded an RCVS Fellowship in 2016 for Meritorious Contributions to Clinical Practice, Dr Sturgess is an active clinician, splitting his time between veterinary clinics and in charity roles, writing, teaching and examining.
Discussing his new role, Dr Sturgess said:“I am very honoured to become Cats Protection’s new Chair of Trustees, especially at a time when the charity is delivering an ambitious strategy to have a huge impact on the health, welfare and well-being of the UK’s cats.
“By harnessing the talent among our volunteers and staff, we hope to help more cats and the people that love them.”
Image (C) Cats Protection
Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.
